{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:55:51Z","timestamp":1788904551463,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.suc.2018.04.001","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T16:33:24Z","timestamp":1527698004000},"page":"747-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Management of the Axilla in the\u00a0Patient with Breast Cancer"],"prefix":"10.1016","volume":"98","author":[{"given":"Ko Un","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Caudle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2018.04.001_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","article-title":"Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases","volume":"63","author":"Carter","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2018.04.001_bib2","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/01.SLA.0000065289.06765.71","article-title":"Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer","volume":"237","author":"Beenken","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib3","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.suc.2018.04.001_bib4","first-page":"169","article-title":"Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings","volume":"12","author":"Sacre","year":"1986","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib5","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/cncr.10786","article-title":"Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma","volume":"95","author":"Krishnamurthy","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2018.04.001_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cncr.23344","article-title":"Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation","volume":"114","author":"Alkuwari","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2018.04.001_bib7","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Breast, Version 2.2017, BINV-11. Available at: www.nccn.org. Accessed September 1, 2017."},{"key":"10.1016\/j.suc.2018.04.001_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3322\/caac.21393","article-title":"Breast cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Giuliano","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.suc.2018.04.001_bib9","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.suc.2018.04.001_bib11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJM199810013391401","article-title":"The sentinel node in breast cancer\u2013a multicenter validation study","volume":"339","author":"Krag","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2018.04.001_bib13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A\u00a0randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2018.04.001_bib15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.suc.2018.04.001_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","article-title":"Improved axillary staging of breast cancer with sentinel lymphadenectomy","volume":"222","author":"Giuliano","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib18","first-page":"210","article-title":"American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer","volume":"24","author":"Lyman","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.suc.2018.04.001_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1245\/s10434-010-1253-3","article-title":"Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database","volume":"17","author":"Yi","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib20","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1200\/JCO.2008.19.5750","article-title":"Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer","volume":"27","author":"Bilimoria","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.suc.2018.04.001_bib22","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2010.28.18_suppl.cra506","article-title":"ACOSOG Z0011: a randomized trial of axillary node dissection in women with clincial T1-2 N0M0 breast cancer who have a positive sentinel node","volume":"28","author":"Giuliano","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.suc.2018.04.001_bib25","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (alliance) trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib26","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1200\/JCO.2011.36.1667","article-title":"Positive sentinel nodes without axillary dissection: implications for the radiation oncologist","volume":"29","author":"Haffty","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib28","unstructured":"National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Breast, Version 2017. Available at: www.nccn.org. Accessed August 22, 2018."},{"key":"10.1016\/j.suc.2018.04.001_bib29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib30","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1245\/s10434-011-1593-7","article-title":"Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial","volume":"19","author":"Caudle","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib31","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1245\/s10434-012-2531-z","article-title":"American College of Surgeons (ACOSOG) Z0011: impact on surgeon practice patterns","volume":"19","author":"Caudle","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2017.10.007","article-title":"Expanding implementation of ACOSOG Z0011 in surgeon practice","author":"Weiss","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.suc.2018.04.001_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jamcollsurg.2015.02.035","article-title":"Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer","volume":"221","author":"Yao","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib34","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1245\/s10434-016-5327-8","article-title":"Measures of appropriateness and value for breast surgeons and their patients: the American Society of Breast Surgeons Choosing Wisely (\u00ae) Initiative","volume":"23","author":"Landercasper","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib35","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1245\/s10434-014-3813-4","article-title":"Predicting the extent of nodal disease in early-stage breast cancer","volume":"21","author":"Caudle","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1245\/s10434-015-4944-y","article-title":"Does a positive axillary lymph node needle biopsy result predict the need for an axillary lymph node dissection in clinically node-negative breast cancer patients in the ACOSOG Z0011 era?","volume":"23","author":"Pilewskie","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib37","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1245\/s10434-016-5605-5","article-title":"Outcomes of sentinel lymph node-positive breast cancer patients treated with mastectomy without axillary therapy","volume":"24","author":"FitzSullivan","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12885-015-1613-2","article-title":"The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)","volume":"15","author":"van Roozendaal","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.suc.2018.04.001_bib39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2011.1034","article-title":"Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer","volume":"306","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.suc.2018.04.001_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1008108","article-title":"Effect of occult metastases on survival in node-negative breast cancer","volume":"364","author":"Weaver","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suc.2018.04.001_bib41","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1245\/s10434-008-0153-2","article-title":"Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients","volume":"15","author":"Mittendorf","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib42","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/jcp.2005.029991","article-title":"The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma","volume":"59","author":"Cserni","year":"2006","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.suc.2018.04.001_bib43","unstructured":"Oncology SoS. Choosing Wisely Campaign. Available at: www.choosingwisely.org\/clinician-lists\/sso-sentinel-node-biopsy-in-node-negative-women-70-and-over. Accessed October 22, 2017."},{"key":"10.1016\/j.suc.2018.04.001_bib44","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib45","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/SLA.0b013e31827660a8","article-title":"Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial","volume":"256","author":"Martelli","year":"2012","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.suc.2018.04.001_bib46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib47","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ejca.2015.03.014","article-title":"Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: identification rate and influence on axillary treatment","volume":"51","author":"van der Heiden-ven der Loo","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.suc.2018.04.001_bib48","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (alliance) prospective multicenter clinical trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib49","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","article-title":"The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer","volume":"19","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib50","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.2008.18.3228","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study","volume":"27","author":"Classe","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib51","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-007-9403-y","article-title":"Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation","volume":"14","author":"Newman","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib52","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1245\/ASO.2003.05.012","article-title":"Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer","volume":"10","author":"Balch","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib53","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.suc.2018.04.001_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib55","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib56","doi-asserted-by":"crossref","unstructured":"Boughey J, Ballman K, Symmans W, et\u00a0al. Methods impacting the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4,N1-2) who receive neoadjuvant chemotherapy \u2013 Results from a prospective trial \u2013 ACOSOG Z1071 (Alliance). Available at: http:\/\/eposter.abstractsonline.com\/sabcs. Accessed January 31, 2015.","DOI":"10.1158\/1538-7445.SABCS14-P2-01-02"},{"key":"10.1016\/j.suc.2018.04.001_bib57","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1200\/JCO.2014.57.8401","article-title":"Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance)","volume":"33","author":"Boughey","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.breast.2016.11.012","article-title":"Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial","volume":"31","author":"Schwentner","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.suc.2018.04.001_bib59","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib60","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib61","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1245\/s10434-015-5052-8","article-title":"Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes","volume":"23","author":"Diego","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.suc.2018.04.001_bib62","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1245\/s10434-017-6023-z","article-title":"Localizing the clipped node in patients with node-positive breast cancer treated with neoadjuvant chemotherapy: early learning experience and challenges","volume":"24","author":"Nguyen","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib63","first-page":"1072","article-title":"Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial","volume":"34","author":"Caudle","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib64","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1245\/s10434-010-1008-1","article-title":"The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy","volume":"17","author":"Straver","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suc.2018.04.001_bib65","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2018.04.001_bib66","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.clbc.2017.04.006","volume":"17","author":"van Nijnatten","year":"2017","journal-title":"Clin Breast Cancer"},{"issue":"10","key":"10.1016\/j.suc.2018.04.001_bib67","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1245\/s10434-017-5958-4","article-title":"Use of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American Society of breast surgeons members","volume":"24","author":"Caudle","year":"2017","journal-title":"Ann Surg Oncol"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610918300604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610918300604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T19:01:57Z","timestamp":1661367717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610918300604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0039610918300604"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2018.04.001","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of the Axilla in the\u00a0Patient with Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2018.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}